Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes

The identification of new predictive biomarkers and therapeutic target for tailored therapy in breast cancer onset and progression is an interesting challenge. OLR-1 gene encodes the cell membrane receptor LOX-1 (lectin-like oxidized low-density lipoprotein receptor). We have recently identified a n...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Autores principales: Pucci, Sabina, Polidoro, Chiara, Greggi, Chiara, Amati, Francesca, Morini, Elena, Murdocca, Michela, Biancolella, Michela, Orlandi, Augusto, Sangiuolo, Federica, Novelli, Giuseppe
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6362207/
https://ncbi.nlm.nih.gov/pubmed/30718451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-1279-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares